Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05613023

A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT

PACE-NODES. A Phase III Randomised Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
1,128 (estimated)
Sponsor
Institute of Cancer Research, United Kingdom · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will compare the safety and efficacy of curative radiotherapy to the prostate and lymph glands given in 5 visits to that of prostate alone radiotherapy given in 5 visits, in men with high risk localised prostate cancer.

Detailed description

This study will look at the safety of curative radiotherapy to the prostate and lymph glands given in 5 visits, in men with high risk localised prostate cancer. The purpose of the research is to test an advanced type of external beam radiotherapy called stereotactic body radiotherapy (also known as SBRT) in 1128 participants with high risk localised prostate cancer (that is, prostate cancer that has not spread beyond the prostate gland but is at high risk of growing quickly or spreading). Importantly, this treatment delivers a potentially curative dose of radiotherapy in only 5 treatments over two weeks. Half the participants in the trial will receive radiotherapy to the prostate, the other half will have radiotherapy to the prostate as well as the surrounding lymph nodes. The investigators will follow patients in the trial for at least three and half years to see which treatment is best. The investigators will be looking at whether it is safe to give this treatment by reviewing any side-effects that occur and also assessing whether giving SBRT to the lymph nodes as well as the prostate reduces the chance of prostate cancer returning. The treatment will take place at NHS radiotherapy centres that are experienced in giving SBRT and radiotherapy to the pelvic nodes, and have been quality assured to deliver these treatments

Conditions

Interventions

TypeNameDescription
RADIATIONSBRTStereotactic Body Radiotherapy

Timeline

Start date
2022-09-09
Primary completion
2028-06-01
Completion
2030-06-01
First posted
2022-11-14
Last updated
2024-09-19

Locations

42 sites across 3 countries: Ireland, New Zealand, United Kingdom

Source: ClinicalTrials.gov record NCT05613023. Inclusion in this directory is not an endorsement.